Literature DB >> 11181399

Estrogen-induced cardiorenal protection: potential cellular, biochemical, and molecular mechanisms.

R K Dubey1, E K Jackson.   

Abstract

A number of cellular and biochemical processes are involved in the pathophysiology of glomerular and vascular remodeling, leading to renal and vascular disorders, respectively. Although estradiol protects the renal and cardiovascular systems, the mechanisms involved remain unclear. In this review we provide a discussion of the cellular, biochemical, and molecular mechanisms by which estradiol may exert protective effects on the kidneys and vascular wall. In this regard, we consider the possible role of genomic vs. nongenomic mechanisms and estrogen receptor-dependent vs. estrogen receptor-independent mechanisms in mediating the protective effects of estradiol on the renal and cardiovascular systems.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181399     DOI: 10.1152/ajprenal.2001.280.3.F365

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  63 in total

Review 1.  Effects of gender on the renin-angiotensin system, blood pressure, and renal function.

Authors:  Amrit K Kang; Judith A Miller
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

2.  Sex-Related Disparities in CKD Progression.

Authors:  Ana C Ricardo; Wei Yang; Daohang Sha; Lawrence J Appel; Jing Chen; Marie Krousel-Wood; Anjella Manoharan; Susan Steigerwalt; Jackson Wright; Mahboob Rahman; Sylvia E Rosas; Milda Saunders; Kumar Sharma; Martha L Daviglus; James P Lash
Journal:  J Am Soc Nephrol       Date:  2018-12-03       Impact factor: 10.121

3.  Candidate genes and mechanisms for 2-methoxyestradiol-mediated vasoprotection.

Authors:  Federica Barchiesi; Eliana Lucchinetti; Michael Zaugg; Omolara O Ogunshola; Matthew Wright; Markus Meyer; Marinella Rosselli; Sara Schaufelberger; Delbert G Gillespie; Edwin K Jackson; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-10-04       Impact factor: 10.190

4.  2-Hydroxyestradiol slows progression of experimental polycystic kidney disease.

Authors:  Sharon Anderson; Terry T Oyama; Jessie N Lindsley; William E Schutzer; Douglas R Beard; Vincent H Gattone; Radko Komers
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

5.  Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells.

Authors:  Raghvendra K Dubey; Edwin K Jackson; Delbert G Gillespie; Lefteris C Zacharia; Bruno Imthurn; Marinella Rosselli
Journal:  J Clin Endocrinol Metab       Date:  2010-06-09       Impact factor: 5.958

6.  Estradiol stimulates capillary formation by human endothelial progenitor cells: role of estrogen receptor-{alpha}/{beta}, heme oxygenase 1, and tyrosine kinase.

Authors:  Isabella Baruscotti; Federica Barchiesi; Edwin K Jackson; Bruno Imthurn; Ruth Stiller; Jai-Hyun Kim; Sara Schaufelberger; Marinella Rosselli; Christopher C W Hughes; Raghvendra K Dubey
Journal:  Hypertension       Date:  2010-07-19       Impact factor: 10.190

7.  Male Patients may be More Vulnerable to Acute Kidney Injury After Colorectal Surgery in an Enhanced Recovery Program: A Propensity Score Matching Analysis.

Authors:  Jung-Woo Shim; Hojun Ro; Chul Seung Lee; Jaesik Park; Hyung Mook Lee; Yong-Suk Kim; Young Eun Moon; Sang Hyun Hong; Min Suk Chae
Journal:  World J Surg       Date:  2021-03-15       Impact factor: 3.352

Review 8.  Sexual dimorphism in the aging kidney: differences in the nitric oxide system.

Authors:  Chris Baylis
Journal:  Nat Rev Nephrol       Date:  2009-06-02       Impact factor: 28.314

9.  Endogenous sex steroid hormones and measures of chronic kidney disease (CKD) in a nationally representative sample of men.

Authors:  Stella Yi; Elizabeth Selvin; Sabine Rohrmann; Shehzad Basaria; Andy Menke; Nader Rifai; Eliseo Guallar; Elizabeth A Platz; Brad Astor
Journal:  Clin Endocrinol (Oxf)       Date:  2008-10-21       Impact factor: 3.478

10.  Sexual dimorphism, the aging kidney, and involvement of nitric oxide deficiency.

Authors:  Chris Baylis
Journal:  Semin Nephrol       Date:  2009-11       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.